Peng Yang
China Pharmaceutical University
H-index: 25
Asia-China
Top articles of Peng Yang
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Discovery of potent and selective c-Met inhibitors for MET-amplified hepatocellular carcinoma treatment | European Journal of Medicinal Chemistry | Wenjian Min Yanyin Wang Hongtao Shen Mingming Zheng Chen Tong | 2024/1/15 |
Heterogeneities of the lithospheric thermal structure and rheology control Cenozoic intracontinental deformation in southeast China | Tectonophysics | Peng Yang Shaowen Liu | 2024/1/9 |
Comprehensive analyses reveal molecular and clinical characteristics of RNA modification writers across 32 cancer types | Cancer Insight | Jiayu Ding Hao Shen Jiaying Ji Jiaxing Li Wenbin Kuang | 2024/6/15 |
Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection | European Journal of Medicinal Chemistry | Shuang Mei Yunting Zou Su Jiang Lu Xue Yuting Wang | 2024/1/5 |
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting C797S Mutation | Future Journal of Pharmaceutical Sciences | Iten M Fawzy Khairia M Youssef Nasser SM Ismail Joachim Gullbo Khaled AM Abouzid | 2015/6/1 |
Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors | Bioorganic & medicinal chemistry | Ana R Gomes Ana S Pires Ana M Abrantes Ana C Goncalves Saul C Costa | 2021/9/15 |
Molecules inducing specific cyclin-dependent kinase degradation and their possible use in cancer therapy | Mingming Zheng Xiao-Yu Zhang Weijiao Chen Fei Xia Huanaoyu Yang | 2024/2 | |
PJA2 suppresses colorectal cancer progression by controlling HDAC2 degradation and stability. | Zhihao Chen Peng Yang Chi Jin Tuo Wang Ye Wang | 2023/11/20 | |
Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers | Yishi Xie Wenbin Kuang Dawei Wang Kai Yuan Peng Yang | 2023/3/15 | |
Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer Treatment | Journal of Medicinal Chemistry | Siyu He Xianglin Chu Yujia Wu Jiheng Jiang Pengfei Fang | 2023/7/6 |
Discovery of Novel Fourth-Generation EGFR Inhibitors to Overcome C797S-Mediated Resistance | Journal of Medicinal Chemistry | Yasheng Zhu Xiuquan Ye Hao Shen Jiaxing Li Zeyu Cai | 2023/10/27 |
UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3 | Oncogene | Tuo Wang Chi Jin Peng Yang Zhihao Chen Jiangzhou Ji | 2023/2/24 |
Pan-cancer analysis of DNA methyltransferase family with potential implications in prognosis and immunology in human cancer | Genes & Diseases | Jiayu Ding Hao Shen Dawei Wang Wenbin Kuang Liping Wang | 2023/7 |
Inverse design of chiral functional films by a robotic AI-guided system | Nature Communications | Yifan Xie Shuo Feng Linxiao Deng Aoran Cai Liyu Gan | 2023/10/4 |
Discovery of potent DYRK2 inhibitors with high selectivity, great solubility, and excellent safety properties for the treatment of prostate cancer | Journal of Medicinal Chemistry | Kai Yuan Hongtao Shen Mingming Zheng Fei Xia Qiannan Li | 2023/2/17 |
Bispecific antibodies in cancer therapy: Target selection and regulatory requirements | Yanze Sun Xinmiao Yu Xiao Wang Kai Yuan Gefei Wang | 2023/5/23 | |
Cdk6/dyrk2 dual-target inhibitor, and preparation method therefor and use thereof | 2023/9/28 | ||
Overcoming MTDH and MTDH-SND1 complex: Driver and potential therapeutic target of cancer | Cancer Insight | Hao Shen Jiayu Ding Jiaying Ji Binjian Jiang Xiao Wang | 2023/12/11 |
Development of highly potent and specific AKR1C3 inhibitors to restore the chemosensitivity of drug-resistant breast cancer | European journal of medicinal chemistry | Yang Liu Yuting Chen Jiheng Jiang Xianglin Chu Qinglong Guo | 2023/2/5 |
Discovery of potent and wild-type-sparing fourth-generation EGFR Inhibitors for treatment of osimertinib-resistance NSCLC | Journal of Medicinal Chemistry | Haojie Dong Xiuquan Ye Yasheng Zhu Hao Shen Hongtao Shen | 2023/5/4 |
